Evidence map›Paper›PMID 40845842›Full record

ArticleImmunity2025

Transcription factor BACH2 shapes tissue-resident memory T cell programs to promote HIV-1 persistence.

Yulong Wei, Haocong Katherine Ma, Michelle E Wong, Hyein Back, Emmanouil Papasavvas, Karam Mounzer, Faten Aberra, Ricardo Morgenstern, Pablo Tebas, Liza Konnikova and 2 more

Abstract read
In one paragraph

Article in Immunity, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Group 2 innate lymphoid cells: Where are we 15 years out?The Journal of allergy and clinical immunology · 2026
    Review
  5. Review
  6. Article
  7. Article
  8. Early immune responses anticipate HIV rebound and precede viral control.bioRxiv : the preprint server for biology · 2026
    Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. TheInternational journal of hypertension · 2026
    Article
  14. Persistent CD4Frontiers in immunology · 2026
    Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors.

Yulong WeiDepartment of Microbial Pathogenesis, Yale University School of Medicine, New Haven, CT 06519, USA. Electronic address: yulong.wei@yale.edu.
Haocong Katherine MaDepartment of Microbial Pathogenesis, Yale University School of Medicine, New Haven, CT 06519, USA.
Michelle E WongDepartment of Microbial Pathogenesis, Yale University School of Medicine, New Haven, CT 06519, USA.
Hyein BackDepartment of Microbial Pathogenesis, Yale University School of Medicine, New Haven, CT 06519, USA.
Emmanouil PapasavvasHIV Cure and Viral Diseases Center, Wistar Institute, Philadelphia, PA 19104, USA.
Karam MounzerThe Jonathan Lax Immune Disorders Treatment Center, Philadelphia FIGHT, Philadelphia, PA 19107, USA.
Faten AberraDivision of Gastroenterology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104, USA.
Ricardo MorgensternDivision of Gastroenterology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104, USA.
Pablo TebasDivision of Infectious Diseases, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104, USA.
Liza KonnikovaDepartment of Pediatrics, Yale University School of Medicine, New Haven, CT 06519, USA.
Luis J MontanerHIV Cure and Viral Diseases Center, Wistar Institute, Philadelphia, PA 19104, USA.
Ya-Chi HoDepartment of Microbial Pathogenesis, Yale University School of Medicine, New Haven, CT 06519, USA. Electronic address: ya-chi.ho@yale.edu.

Funding

BEAT-HIV: Delaney Collaboratory to Cure HIV-1 Infection by Combination ImmunotherapyUM1AI164570 · NIAID · WISTAR INSTITUTE · PI Luis J Montaner, James L. Riley · 2021 to 2026
$34.7M
CHEETAH Center for the Structural Biology of HIV Infection, Restriction, and Viral DynamicsU54AI170856 · NIAID · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI WESLEY I. SUNDQUIST · 2022 to 2026
$34.4M
REACH: Research Enterprise to Advance a Cure for HIVUM1AI164565 · NIAID · WEILL MEDICAL COLL OF CORNELL UNIV · PI Marina Caskey, R. Brad Jones · 2021 to 2026
$32.9M
The Y-SCORCH Data Generation Center at Yale for Single-Cell Opioid Responses in the Context of HIVUM1DA051410 · NIDA · YALE UNIVERSITY · PI GERSTEIN, MARK BENDER, KLUGER, YUVAL · 2020 to 2025
$15.3M
High-Definition Characterization of the Persistence and Perturbation of the HIV Reservoir: Project 3P01AI169768 · NIAID · BRIGHAM AND WOMEN'S HOSPITAL · PI Ya-Chi Ho, Jonathan Li · 2022 to 2026
$10.1M
M-SCORCH: Methamphetamine use disorder data generation center for Single Cell Opioid Responses in the Context of HIVU01DA053628 · NIDA · YALE UNIVERSITY · PI HO, YA-CHI, SESTAN, NENAD · 2021 to 2025
$9.5M
Towards Eradication: Reducing Proviral HIV DNA with Interferon-α ImmunotherapyU01AI110434 · NIAID · WISTAR INSTITUTE · PI MONTANER, LUIS J · 2014 to 2017
$7.2M
Individualized HIV Curative Combination Strategy against Persistent HIV on ARTUM1AI191272 · NIAID · WISTAR INSTITUTE · PI Luis J Montaner, ROBERT F SILICIANO · 2025 to 2026
$6.9M
Role of clonal expansion in HIV-1 persistenceR01AI141009 · NIAID · YALE UNIVERSITY · PI Ya-Chi Ho · 2018 to 2026
$5.3M
Understanding HIV-1 persistence in cytotoxic CD4+ T lymphocytes at the single cell levelR01AI174863 · NIAID · YALE UNIVERSITY · PI Ya-Chi Ho · 2023 to 2026
$3.4M
Enhancing Susceptibility of HIV Reservoirs to CTL Through a Discovery to Translational ApproachR01AI176601 · NIAID · WEILL MEDICAL COLL OF CORNELL UNIV · PI R. Brad Jones, Neville Sanjana · 2023 to 2026
$3.3M
A Big Data Approach to Identify Epigenetic, Transcriptomic, and Network Dynamics as Immune Dysfunction Drivers Associated with HIV Infection and Substance Use DisorderR01DA051906 · NIDA · YALE UNIVERSITY · PI GERSTEIN, MARK BENDER · 2020 to 2024
$2.8M
NIAID NIH HHS P01 AI169768NIAID NIH HHS R01 AI141009NIAID NIH HHS R01 AI174863NIAID NIH HHS R01 AI176601NIAID NIH HHS R01 AI183430NIAID NIH HHS U01 AI110434NIAID NIH HHS U54 AI170856NIAID NIH HHS UM1 AI164565NIAID NIH HHS UM1 AI164570NIAID NIH HHS UM1 AI191272NIDA NIH HHS R01 DA051906NIDA NIH HHS R33 DA047037NIDA NIH HHS U01 DA053628NIDA NIH HHS UM1 DA051410
6 · The paper itself

Abstract

Tissue-resident memory T cells (Trms) are essential for mucosal immunity. We postulated that their long-lived tissue residency and restricted effector function promoted HIV-1 persistence in the gut. We coupled single-cell DOGMA-seq and TREK-seq to capture chromatin accessibility, transcriptome, surface proteins, T cell receptors (TCRs), HIV-1 DNA, and HIV-1 RNA in gut CD4

Indexed as

Basic-Leucine Zipper Transcription FactorsCD4-Positive T-LymphocytesCD8-Positive T-LymphocytesHIV-1HIV InfectionsImmunologic MemoryMemory T CellsHumansImmunity, MucosalBACH2 protein, humanBasic-Leucine Zipper Transcription FactorsBACH2gutHIV-1 reservoirHIV-1-specific CD8(+) T cellsHIV curemucosal immunitysingle-cell multi-omicsT cell clonal expansionT cell homeostasistissue-resident memory T cell

Identifiers

PMID40845842
PMCPMC12385486

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.